Strong human endogenous retrovirus-specific T cell responses are associated with control of HIV-1 in chronic infection. - Wikidata - awgldk - TriplyDB

Strong human endogenous retrovirus-specific T cell responses are associated with control of HIV-1 in chronic infection.

Strong human endogenous retrovirus-specific T cell responses are associated with control of HIV-1 in chronic infection.

http://www.wikidata.org/entity/Q35077813

about

'There and back again': revisiting the pathophysiological roles of human endogenous retroviruses in the post-genomic era Inside the Envelope: Endogenous Retrovirus-K Env as a Biomarker and Therapeutic Target Vaccination against endogenous retrotransposable element consensus sequences does not protect rhesus macaques from SIVsmE660 infection and replication HIV-1 infection leads to increased transcription of human endogenous retrovirus HERV-K (HML-2) proviruses in vivo but not to increased virion production.Evaluation of cynomolgus macaque (Macaca fascicularis) endogenous retrovirus expression following simian immunodeficiency virus infection.Human endogenous retrovirus expression is inversely associated with chronic immune activation in HIV-1 infection.HERV-K(HML-2), a seemingly silent subtenant - but still waters run deep.Vaccination directed against the human endogenous retrovirus-K envelope protein inhibits tumor growth in a murine model system.Therapeutic DNA vaccination of vertically HIV-infected children: report of the first pediatric randomised trial (PEDVAC)HIV-Specific CD8(+) T Lymphocytes in Blood of Long-Term HIV-Infected Hemophilia Patients.Identification of human endogenous retrovirus-specific T cell responses in vertically HIV-1-infected subjects.Human endogenous retrovirus K(HML-2) Gag- and Env-specific T-cell responses are infrequently detected in HIV-1-infected subjects using standard peptide matrix-based screening.Immunotherapy with an HIV-DNA Vaccine in Children and Adults.Gene activity in primary T cells infected with HIV89.6: intron retention and induction of genomic repeats.Vaccination with cancer- and HIV infection-associated endogenous retrotransposable elements is safe and immunogenic Human endogenous retrovirus K Gag coassembles with HIV-1 Gag and reduces the release efficiency and infectivity of HIV-1.Further Evidence that Human Endogenous Retrovirus K102 is a Replication Competent Foamy Virus that may Antagonize HIV-1 Replication HERV-K-specific T cells eliminate diverse HIV-1/2 and SIV primary isolates.HERV-H RNA is abundant in human embryonic stem cells and a precise marker for pluripotency.Human endogenous retrovirus K(HML-2) Gag and Env specific T-cell responses are not detected in HTLV-I-infected subjects using standard peptide screening methods.Endogenous retrovirus-K promoter: a landing strip for inflammatory transcription factors?HERV-K(HML-2), the Best Preserved Family of HERVs: Endogenization, Expression, and Implications in Health and Disease.Trans-activation, post-transcriptional maturation, and induction of antibodies to HERV-K (HML-2) envelope transmembrane protein in HIV-1 infection.Vaccination directed against the human endogenous retrovirus-K (HERV-K) gag protein slows HERV-K gag expressing cell growth in a murine model system.HIV infection and HERV expression: a review.Human endogenous retroviruses and cancer: causality and therapeutic possibilities.Anti-HERV-K (HML-2) capsid antibody responses in HIV elite controllers.Modulation of human endogenous retrovirus (HERV) transcription during persistent and de novo HIV-1 infection.ERVK polyprotein processing and reverse transcriptase expression in human cell line models of neurological disease.Expression of human endogenous retrovirus K and W in babies.Increased seroreactivity to HERV-K10 peptides in patients with HTLV myelopathy.Endogenous retrovirus sequences as a novel class of tumor-specific antigens: an example of HERV-H env encoding strong CTL epitopes.Molecular mechanisms by which HERV-K Gag interferes with HIV-1 Gag assembly and particle infectivity.Natural and cross-inducible anti-SIV antibodies in Mauritian cynomolgus macaques.HIV-1 Infection of Primary CD4+ T Cells Regulates the Expression of Specific Human Endogenous Retrovirus HERV-K (HML-2) Elements.Hypothetical endogenous SIV-like antigens in Mauritian cynomolgus macaques.

P2860

Q24289157-0828B5C6-35AC-4FFB-8AE1-1A64DC4A84DC Q26776132-C3893ABA-4823-4122-90E4-71364BEAB78B Q27315009-E22371F7-F631-4C3B-99A9-CF1191A7928E Q34262010-29B92A69-98D4-4826-BF8F-97B82C71F51D Q34328720-70C59FC6-8DDC-444A-B014-E9A94393B822 Q34373981-C9449E25-9933-4E70-B3B7-923EA9CE4448 Q34511101-095BAC72-DA91-4107-9F53-3E855CA21BD7 Q34983603-30555D2F-1390-4315-A9DE-339D643BDCD4 Q35060232-7FCE2E4C-D5A1-4F33-8ACD-033384123B42 Q35079104-AE08B07A-CC50-4939-B3C8-34C24B24D013 Q35363070-147450A6-8D6D-4E5E-BB7A-0AF7BA8FE12B Q35739088-0659617C-162B-45C7-9D44-D17E1EBF5CD9 Q35826642-6ACA54E4-E711-47BC-B537-17FA14BA2E0A Q36071452-8721B7B3-019D-4EED-8F77-8FAC13E31BAB Q36106578-1ADE5053-9E68-4DC4-A8AF-52A4E2A04B68 Q36276266-C4E96151-16E9-4E1C-931A-703D5D9D5C4E Q36466553-1E28F58E-ACD9-440B-BF18-C84D25183A73 Q36498080-F97AE475-85F4-457A-9D47-5C4B8D3EE811 Q36571971-C5E7B5D0-2515-4F43-8A99-E7BB472A8979 Q36575342-48DC30C2-2F3B-4C64-96AB-2C606F511849 Q36687211-3E9FBCA0-03C5-43FC-8487-D2E36CF16838 Q37186225-EDF890C5-F6A6-4D55-8003-6E3BA8971511 Q37534896-A24C7745-F4E1-4081-B48B-61497E128548 Q37682344-4F188740-14EC-49B7-B113-AA5F695CC8A0 Q37976105-CD1B5E5C-8851-4DB3-B572-08BDEFDDC9EB Q38060116-2D8AD283-20A4-4BCD-B5E9-F3333B796353 Q38613558-041DA5A3-DDC9-4E92-8928-CF5DAA1E1159 Q38885663-1018AF8E-ECBA-49C5-A5DA-B144DC52A4A3 Q38917776-6FE96D3E-145D-44E2-B2EF-637CB701D481 Q39292834-AC2BDBB6-381C-451D-A98F-8B8B0D69C780 Q39351148-C2A02451-ED9E-4D17-8A68-43A86987C4D5 Q39424744-7E9BA01A-3BDF-4297-8330-5D656BDC4D85 Q40226566-6F1B8776-B37C-49D2-B536-61D299AD0BC0 Q41923513-8F54CAC5-39AB-41AB-A2BC-122C7201847E Q42697771-83A0ADFA-B703-4344-97DB-93006C9B91A3 Q52721500-BDD098C2-EFB8-48F0-96AA-10AA0D6C3AA6

P2860

Strong human endogenous retrovirus-specific T cell responses are associated with control of HIV-1 in chronic infection.

http://www.wikidata.org/entity/Q35077813

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Strong human endogenous retrov ...... of HIV-1 in chronic infection.

@ast

Strong human endogenous retrov ...... of HIV-1 in chronic infection.

@en

type

label

Strong human endogenous retrov ...... of HIV-1 in chronic infection.

@ast

Strong human endogenous retrov ...... of HIV-1 in chronic infection.

@en

prefLabel

Strong human endogenous retrov ...... of HIV-1 in chronic infection.

@ast

Strong human endogenous retrov ...... of HIV-1 in chronic infection.

@en

P1433

Q35077813-1D135E31-7E39-4DAD-84D6-FF8CE392ECAC

P1476

Q35077813-21107BCE-7EC9-4F4A-BEDF-CA32807624DF

P2093

Q35077813-1AF22189-11F2-4260-9DBA-33282DC7F655

Q35077813-1B749A47-973B-4F00-8FC4-21ACED4A2C0F

Q35077813-1D3DCDC3-11BD-4AE6-9F02-78DED697113E

Q35077813-329621FD-2F5A-473F-A012-5C561D27E0E9

Q35077813-3ABA9F3E-2F5B-455F-A1EC-3F11BF965041

Q35077813-5E004A3B-CA1E-4895-93C9-2209D6D6C3FD

Q35077813-675F7B7E-0559-4613-A17D-163C00560C1B

Q35077813-73533D57-8313-4EB7-BE55-6003EF94036E

Q35077813-A270341A-5DA6-43B4-B06E-539E21A20980

Q35077813-AC73DE7B-9A17-4D4B-8EF6-70865ED4CD2A

P2860

Q35077813-0565C964-0927-448C-9530-C43958AF7B3B

Q35077813-07B4076B-E444-455B-9AD6-0779F58DEA1A

Q35077813-10A9DB41-49BF-40A1-8CD5-E54416ED854A

Q35077813-18031BFC-7EE0-4EFD-A226-8F2920BBBCEC

Q35077813-19546FC7-E19E-4932-96BE-C45D1B1F322D

Q35077813-23F0C773-2E02-4F88-A60F-7ACC1228B731

Q35077813-3B83D726-003E-4B62-B8BF-4B1EE7B4CC03

Q35077813-4CBBFD38-1A8E-48E7-90BA-3F90C5B3A8E9

Q35077813-57C20DB1-2C3F-4C0B-B06A-B555C5DB2C98

Q35077813-59120F01-393A-4769-92BC-86273FC7A6C6

P304

Q35077813-38DF2D16-FA2D-470B-A3FA-5ABCEBC42020

P31

Q35077813-B8099754-1A2C-4206-B157-9708747B28F0

P356

Q35077813-8853BA39-8D59-43EF-8E1B-3F0D8558EED0

P407

Q35077813-FAC3C878-081E-4B65-9AC7-D4B83084C4D7

P433

Q35077813-3400236E-02CA-48BF-A201-6F2E29255799

P478

Q35077813-1887C624-57A3-4EF0-B2E2-393F063F82EE

P50

Q35077813-42FC299C-CD1C-43E0-823E-7A5FEA6ABBA6

Q35077813-647D8858-EE93-45D4-9329-DF685E897795

Q35077813-F61FCFA7-ADE3-4E3E-B142-BB908B8D839E

P577

Q35077813-7460F666-3469-44D7-8095-A33D72200912

P5875

Q35077813-3E7DA251-7E79-45CD-9E96-78F49C3BA602

P698

Q35077813-71F2D8C0-CBED-4E9F-9464-4C0C7015BC96

P932

Q35077813-37B79466-3F90-4757-838E-4B86596D49FD

P356

P1433

Journal of Virology

P1476

Strong human endogenous retrov ...... of HIV-1 in chronic infection.

@en

P2093

Christopher E Ormsby

http://www.w3.org/2001/XMLSchema#string

Devi SenGupta

http://www.w3.org/2001/XMLSchema#string

Gerald Spotts

http://www.w3.org/2001/XMLSchema#string

Gustavo Reyes-Terán

http://www.w3.org/2001/XMLSchema#string

Jeffrey N Martin

http://www.w3.org/2001/XMLSchema#string

Keith E Garrison

http://www.w3.org/2001/XMLSchema#string

Lishomwa C Ndhlovu

http://www.w3.org/2001/XMLSchema#string

Liyen Loh

http://www.w3.org/2001/XMLSchema#string

Mario A Ostrowski

http://www.w3.org/2001/XMLSchema#string

R Brad Jones

http://www.w3.org/2001/XMLSchema#string

P2860

Initial sequencing and analysis of the human genome

T cell responses to human endogenous retroviruses in HIV-1 infection

Retroelements and the human genome: new perspectives on an old relation

The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development?

HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability

The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.

HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells

SYFPEITHI: database for MHC ligands and peptide motifs

Fully differentiated HIV-1 specific CD8+ T effector cells are more frequently detectable in controlled than in progressive HIV-1 infection.

Large-scale validation of methods for cytotoxic T-lymphocyte epitope prediction.

P304

6977-6985

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.00179-11

http://www.w3.org/2001/XMLSchema#string

P407

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

85

http://www.w3.org/2001/XMLSchema#string

P50

Douglas F. Nixon

Frederick M. Hecht

P577

2011-04-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51081999

http://www.w3.org/2001/XMLSchema#string

P698

21525339

http://www.w3.org/2001/XMLSchema#string

P932

3126607

http://www.w3.org/2001/XMLSchema#string